Streetbeat News

Stock Prices

LEGN

Legend Biotech shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:52 am

TTD

The Trade Desk shares are trading higher following better-than-expected Q2 financial results and strong Q3 revenue guidance. Keybanc and Susquehanna have also raised their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:51 am

BTCUSD

ETHUSD

SOLUSD

Crypto analyst DonAlt highlights key levels for Bitcoin, Ethereum, and Solana, suggesting cautious trading. Bitcoin's $60K level is critical, Ethereum shows weakness against Bitcoin, and Solana's recent short trade was profitable. Bitcoin's correlation with the S&P 500 and macro factors are also emphasized.

Portfolio Pulse from Khyathi Dalal

August 09, 2024 | 11:36 am

NGNE

Neurogene (NASDAQ:NGNE) reported a Q2 2024 GAAP EPS of $(1.09), missing the analyst consensus estimate of $(1.06) by 2.83%.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:35 am

FRHC

Freedom Holding Corp. (FRHC) reported Q1 earnings per share (EPS) of $0.57, which is significantly lower than the $1.15 reported in the same quarter last year. The company ended the quarter with cash and equivalents worth $719 million.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:34 am

SHCO

Soho House projects its FY24 revenue to be between $1.20 billion and $1.25 billion, compared to the estimated $1.223 billion.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:33 am

SHCO

Soho House (NYSE:SHCO) reported Q2 2024 GAAP EPS of $(0.17), missing the $(0.11) estimate by 54.55%. However, sales of $305.146M beat the $302.870M estimate by 0.75%, marking a 5.61% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:31 am

ELF

e.l.f Beauty shares are trading lower following the company's Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:26 am

AKRO

Akero Therapeutics (NASDAQ:AKRO) reported a Q2 EPS of $(0.81), beating the analyst estimate of $(0.90). The company's cash and marketable securities as of June 30, 2024, were $848.3M.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 11:25 am

SOLUSD

The newly launched cryptocurrency 'Restore the Republic' (RTR) on the Solana blockchain saw its value plummet by 95% after Eric Trump confirmed it is not an official Trump coin. The token initially surged to a $155 million market cap before the sharp decline. The incident highlights the risky nature of the memecoin market.

Portfolio Pulse from Murtuza Merchant

August 09, 2024 | 11:24 am